Home › Steatotic Liver Disease › Virginia › Norfolk
Steatotic Liver Disease clinical trials in Norfolk, VA
3 studies for Steatotic Liver Disease are looking for participants at sites in and around Norfolk (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
RecruitingPhase 3
- Eximia Research - Norfolk, Norfolk
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
RecruitingPhase 3
- Akero Clinical Study Site, Norfolk
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
RecruitingPhase 3
- GSK Investigational Site, Norfolk
About Steatotic Liver Disease
Steatotic liver disease, formerly called fatty liver disease, happens when too much fat builds up in your liver. Learn about the causes and treatments.
More about Steatotic Liver Disease on MedlinePlus
Steatotic Liver Disease trials in other cities
- San Antonio, TX17 studies
- Miami, FL16 studies
- New York City, NY16 studies
- San Diego, CA14 studies
- Houston, TX13 studies
- Austin, TX13 studies
- Richmond, VA12 studies
- Chandler, AZ10 studies
- Tucson, AZ10 studies
- St. Louis, MO9 studies
- Hialeah, FL9 studies
- Dallas, TX9 studies
Other studies in Norfolk
- Breast Cancer16 studies
- Bladder Cancer8 studies
- Prostate Cancer8 studies
- Abdominal Aortic Aneurysm7 studies
- Ovarian Cancer7 studies
- Non-Small Cell Lung Cancer7 studies
- Cancer (all types)7 studies
- Heart Failure7 studies
- Cardiovascular Disease7 studies
- Spinal Muscular Atrophy6 studies
- Peripheral Arterial Disease5 studies
- Triple-Negative Breast Cancer5 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.